Development of herpes simplex virus 1 vectors for dendritic cell based immunotherapy of malaria
Herpes simplex virus 1 (HSV-1) naturally infects dendritic cells but this prevents the cell from undergoing maturation. Removal of the virus host shutoff protein (vhs) has been shown to improve the ability of both human dendritic cells and mouse bone marrow dendritic cells to mature following virus...
Main Author: | Costigliola, Emanuele |
---|---|
Published: |
University College London (University of London)
2005
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.418007 |
Similar Items
-
Pre-clinical and clinical evaluation of recombinant viral vector vaccines for Falciparum malaria
by: Webster, Daniel
Published: (2006) -
Analysis of DNA and recombinant viral vaccines against P. falciparum in malaria-naïve and malaria-exposed humans
by: Moorthy, Vasee S.
Published: (2004) -
Nitric oxide and transmission-modulating immunity to malaria
by: Ramsey, Christopher Guy Charles
Published: (2003) -
Human cellular immune responses to candidate malaria vaccines
by: Berthoud, Tamara Katherine
Published: (2007) -
Clinical and immunological evaluation of new malaria vaccines encoding the thrombospondin related adhesion protein
by: Bejon, Philip
Published: (2007)